Accelerating transit times and lowering the cost of comparator sourcing for studies in Africa
To understand why sub-Saharan Africa can appear a daunting prospect to a contract research organisation (CRO) or sponsor looking to…
Oximio SMO Group
Latest in
Oximio SMO Group
Clinical trials in Russia: big pharma makes moves but what’s the pipeline impact?
Certain big pharma companies have reconsidered their clinical trial footprint in Russia in response to the Ukraine invasion. Clinical Trials…
By
Filings buzz: 23% increase in industrial automation mentions in Q3 of 2021
AstraZeneca referred to industrial automation the most between October 2020 and September 2021.
By
Clinical trials in Russia: drug development pipeline at risk
Questions swirl on how sanctions against Russia might impact the drug development industry.
By
Taiwan approves Eisai’s Lenvima combo for endometrial carcinoma
Lenvima plus Keytruda reduced mortality and disease progression or mortality risk by 38% and 44%, respectively.
Top medical university in Russia pauses clinical trials, sample transport paralysed
Even if enrollment hiatus is lifted, logistical issues such as sending samples to and from Russia another setback.
By
Magazine: Cutting the carbon footprint of pharma’s supply chain
In this issue: We examine the supply chain for delivering Covid-19 antivirals, and the pharma industry's quest to decarbonise.
By
Profit for patients: can NFTs allow people to monetise their health data?
NFTs could democratise access to health information, but challenges around the nascent technology must first be addressed.
By